| DC Vaccine in Pancreatic Cancer (NCT03592888) | University of Pennsylvania | 2018-11-20 |
| Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease (NCT03770117) | Manchester University NHS Foundation Trust | 2018-10-04 |
| BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NCT03496662) | Washington University School of Medicine | 2018-08-31 |
| CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer (NCT03374852) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-08-01 |
| CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer (NCT03517176) | Lisata Therapeutics, Inc. | 2018-07-31 |
| A Study of Personalized Neoantigen Cancer Vaccines (NCT03794128) | Gritstone bio, Inc. | 2018-07-25 |
| Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions (NCT03486327) | Bracco Diagnostics, Inc | 2018-07-19 |
| Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study (NCT03973736) | Azienda USL Reggio Emilia - IRCCS | 2018-06-15 |
| Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma. (NCT04115527) | Ruijin Hospital | 2018-06-01 |
| Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. (NCT03525392) | Ipsen | 2018-05-03 |
| Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy (NCT03138213) | Tongji Hospital | 2018-05-01 |
| A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer (NCT01676259) | Silenseed Ltd | 2018-03-07 |
| Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms (NCT03435770) | Singapore General Hospital | 2018-03-01 |
| Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) (NCT03415854) | HonorHealth Research Institute | 2018-01-31 |
| A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer (NCT03481920) | PH Research, S.L. | 2018-01-10 |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) (NCT03410030) | HonorHealth Research Institute | 2017-12-15 |
| Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer (NCT03317886) | Wakayama Medical University | 2017-12-01 |
| IACS-010759 in Advanced Cancers (NCT03291938) | M.D. Anderson Cancer Center | 2017-11-13 |
| S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer (NCT03316326) | National Taiwan University Hospital | 2017-11-01 |
| A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer (NCT03257150) | University Health Network, Toronto | 2017-09-22 |
| A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors (NCT03267316) | Cantargia AB | 2017-09-19 |
| PEN-866 in Patients With Advanced Solid Malignancies (NCT03221400) | Tarveda Therapeutics | 2017-08-29 |
| CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer (NCT03012282) | University of Washington | 2017-06-22 |
| A Study Evaluating MM-310 in Patients With Solid Tumors (NCT03076372) | Merrimack Pharmaceuticals | 2017-02-22 |
| A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma (NCT02981342) | Eli Lilly and Company | 2017-01-12 |
| Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery (NCT03687853) | Peking University Third Hospital | 2017-01-01 |
| Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma (NCT02959164) | Mohammed Milhem | 2016-12-05 |
| Olaparib in Treating Patients With Stage IV Pancreatic Cancer (NCT02677038) | M.D. Anderson Cancer Center | 2016-11-11 |
| Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors (NCT02607826) | University Hospital Tuebingen | 2016-11-01 |
| Study of NAC of GA Therapy for Patients With BRPC (NCT02926183) | Wakayama Medical University | 2016-10-01 |
| A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors (NCT02498613) | National Cancer Institute (NCI) | 2016-08-31 |
| Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer (NCT02929797) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2016-08-01 |
| Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended? (NCT02787187) | Ruijin Hospital | 2016-07-01 |
| Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer (NCT02790944) | Ambry Genetics | 2016-05-04 |
| WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer (NCT02757859) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2016-04-27 |
| NGS and TME for Evidence-based Treatment of Pancreatic Cancer (NCT02767700) | Karolinska University Hospital | 2016-04-01 |
| A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups (NCT03693378) | Immunovia, Inc. | 2016-01-19 |
| Study of Tremelimumab in Patients With Advanced Solid Tumors (NCT02527434) | AstraZeneca | 2015-11-02 |
| Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy (NCT02570529) | Yonsei University | 2015-10-01 |
| Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial (NCT02440958) | Yonsei University | 2015-08-28 |
| Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma (NCT02426281) | Samsung Medical Center | 2015-06-04 |
| The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer (NCT04406831) | Nuvance Health | 2015-04-01 |
| A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) (NCT02259114) | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-10-23 |
| Plasma Biomarkers P-DAC, V1 (NCT02050997) | Cancer Trials Ireland | 2014-05-26 |
| A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation (NCT02042378) | pharmaand GmbH | 2014-04-01 |
| A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer (NCT01911416) | University of Utah | 2014-01-01 |
| Pancreatic Cancer Recurrence in the Netherlands (NCT04605237) | UMC Utrecht | 2014-01-01 |
| Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy (NCT02414100) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-12-12 |
| Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial] (NCT01879878) | Heidelberg University | 2013-12-01 |
| A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma (NCT01983410) | Memorial Sloan Kettering Cancer Center | 2013-11-04 |
| Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer (NCT01962909) | University of Virginia | 2013-11-01 |
| Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas (NCT01942629) | Rambam Health Care Campus | 2013-10-01 |
| Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma (NCT06302881) | First Affiliated Hospital of Chongqing Medical University | 2013-01-01 |
| Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy (NCT01658943) | National Cancer Institute (NCI) | 2012-08-01 |
| Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer (NCT01580397) | ImmunityBio, Inc. | 2012-05-16 |
| Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma (NCT01431794) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-12-27 |
| Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) (NCT01096732) | Lisa Bax | 2011-02-01 |
| Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas (NCT01188785) | Silenseed Ltd | 2011-01-01 |
| Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer (NCT01280058) | National Cancer Institute (NCI) | 2010-12-01 |
| Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery (NCT01013649) | National Cancer Institute (NCI) | 2010-04-05 |
| Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery (NCT00669734) | National Cancer Institute (NCI) | 2010-02-01 |
| Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer (NCT04954378) | Peking University Third Hospital | 2010-01-01 |
| Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate (NCT04802993) | Linkoeping University | 2010-01-01 |
| Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer (NCT01547260) | Maria Liljefors | 2009-10-01 |
| GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery (NCT00878163) | National Cancer Institute (NCI) | 2009-03-31 |
| Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer (NCT00307723) | Massachusetts General Hospital | 2006-05-01 |
| CT Pancreas Perfusion (NCT00588367) | Mayo Clinic | 2006-04-01 |
| Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer (NCT02575508) | Roswell Park Cancer Institute | |
| Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma (NCT07083479) | Elicio Therapeutics | |